The Cooper Companies, Inc. Votes to Elect Teresa S. Madden to Fill the New Director Position, with Effect from December 1, 2020
November 12, 2020 at 09:39 pm
Share
On November 12, 2020, The Cooper Companies, Inc. announced that, on recommendation of the Corporate Governance & Nominating Committee, the Board of Directors of the Company voted to expand the size of the Board from 8 directors to 9 directors with effect from December 1, 2020 and to elect Teresa S. Madden to fill the new director position, with effect from December 1, 2020, until her successor is duly elected and qualified or her earlier resignation or removal. Ms. Madden has been determined to be an independent director under New York Stock Exchange listing standards.
The Cooper Companies, Inc. is a global medical device company. The Company operates through two business units: CooperVision and CooperSurgical. CooperVision is engaged in the contact lens industry. CooperVisionâs products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys, Biofinity toric & Biofinity XR toric, Biofinity multifocal, Biofinity toric multifocal, clariti 1 day, clariti 1 day toric, clariti 1 day multifocal, MiSight 1 day, Avaira Vitality and Avaira Vitality toric. CooperSurgical is a fertility and womenâs health company dedicated to assisting women, babies and families around the world. CooperSurgical provides a range of products and services with an emphasis on improving fertility solutions, empowering office-based care, and advancing hospital care within womenâs health. CooperSurgicalâs brands include Paragard, ER-Complete, Fetal Pillow, INSORB, PGT-Complete, RUMI II and others.
THE COOPER COMPANIES, INC. 
